SCHEMBL7696243

SCHEMBL7696243

O=C(Nc1ccc(-c2n[nH]c3c2Cc2ccccc2-3)cc1)c1ccc(F)cc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHEK1 O14757 7/20 0.57
KDR P35968 3/20 0.56
CDK1 P06493 1/20 0.53
CDK2 P24941 1/20 0.53
PTPN1 P18031 2/20 0.49
MAP4K1 Q92918 1/20 0.47
ROCK2 O75116 1/20 0.47
ROCK1 Q13464 1/20 0.47
KIT P10721 1/20 0.46
FLT1 P17948 1/20 0.46
POLB P06746 3/20 0.46
TDP1 Q9NUW8 2/20 0.46
NPC1 O15118 2/20 0.46
KDM4E B2RXH2 1/20 0.46
ALDH1A1 P00352 1/20 0.46
TP53 P04637 1/20 0.46
MAPT P10636 1/20 0.46
THRB P10828 1/20 0.46
PKM P14618 1/20 0.46
BLM P54132 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7094928 0.91 KDR (0.64) CHEK1KDRCDK1CDK2PTPN1
SCHEMBL6994408 0.91 KDR (0.64) CHEK1KDRCDK1CDK2PTPN1
SCHEMBL7091231 0.91 CHEK1 (0.56) CHEK1KDRCDK1CDK2ROCK2
Water SCHEMBL7089950 0.90 KDR (0.63) CHEK1KDRCDK1CDK2PTPN1
SCHEMBL7093397 0.89 CHEK1 (0.54) CHEK1KDRCDK1CDK2ROCK2
SCHEMBL7002081 0.88 CDK1 (0.67) CHEK1KDRCDK1CDK2ROCK2
SCHEMBL6994516 0.88 KDR (0.51) CHEK1KDRNPC1TP53SMN1; SMN2
SCHEMBL7700585 0.86 CHEK1 (0.53) CHEK1KDRCDK1CDK2ROCK2
SCHEMBL7702867 0.86 CHEK1 (0.53) CHEK1KDRCDK1CDK2TDP1
SCHEMBL7703594 0.86 CHEK1 (0.53) CHEK1KDRCDK1CDK2ROCK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6462036-B1 INHIBITING SIGNAL TRANSDUCTION BY MODULATING ACTIVITY OF RECEPTOR AND NONRECEPTOR TYROSINE AND SERINE/THREONINE KINASES TO REGULATE AND MODULATE ABNORMAL OR INAPPROPRIATE CELL PROLIFERATION, DIFFERENTIATION, OR METABOLISM BASF AKTIENGESELLSCHAFT (DE) 2002-10-08 US disclosed